Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
132.14 USD 0.00(0%)
Last update at 2026-11-03T21:00:00Z
VOLUME
13
Market Cap
12850.59M
P/E
64.90

Momentum Score

…

Pro Medicus Limited, a healthcare informatics company, provides medical imaging software and services to hospitals, imaging centers, and health care groups in Australia, Europe, and North America. The company offers Visage RIS, an enterprise-class radiology information system for patient registration, billing, scheduling, typing, HL7 integration, financial reporting, picture archive and communication system (PACS) integration, digital dictation, and voice recognition integration; and Visage RIS/PACS, a solution for imaging needs of organizations. It also provides Visage 7 Enterprise Imaging Platform, a healthcare imaging software for radiologists, physicians, and clinicians for access and visualization capability comprising rapidly viewing 2-D, 3-D, and 4-D medical images, as well as PACS, digital imaging software, training, installation, and professional services and support products; and Visage Ease, a native mobile application for access to medical imaging results stored on a Visage 7 server from iOS devices, including iPad, iPhone, and iTouch. In addition, the company offers Visage Ease Pro for interpreting diagnostic imaging studies; and Promedicus.net, an e-health offering. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
118.64
Low
132.14
High
52 Week Price Range
73.66
Low
207.82
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
132.14
Dividend Yield
0.59%
Revenue TTM
261.69M
Revenue Per Share
2.50
Gross Profit TTM
261.29M
Debt / Equity
0.00
ROE
74.97%
Net Debt
-144.05M
ROCE
35.15%
Diluted EPS TTM
1.81

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 376.99M 163.31M 116.50M 86.13M 63.08M
Net income 264.97M 115.22M 82.79M 60.65M 44.44M
Selling general administrative 45.99M 36.28M 30.38M 24.07M 15.40M
Selling and marketing expenses - 3.74M 2.89M 2.52M 1.95M
Gross profit 210.85M 212.60M 161.20M 124.24M 92.94M
Reconciled depreciation 8.06M 7.24M 8.51M 7.93M 7.32M
Ebit 195.84M 157.61M 112.18M 83.76M 62.33M
Ebitda 203.89M 164.85M 120.69M 91.69M 69.64M
Depreciation and amortization 8.05M 7.24M 8.51M 7.93M 7.32M
Operating income 195.84M 157.61M 114.84M 84.08M 61.31M
Other operating expenses 65.48M 55.29M 49.25M 40.12M 30.10M
Interest expense - - - - 0.00M
Tax provision 112.17M 48.09M 33.70M 25.48M 18.64M
Interest income 9.06M 7.56M 4.83M 2.43M 0.65M
Net interest income 9.06M 7.56M 4.83M 2.43M 0.65M
Income tax expense 112.02M 48.09M 33.70M 25.48M 18.64M
Total revenue 261.32M 212.91M 161.50M 124.79M 93.40M
Total operating expenses 15.01M 54.98M 46.36M 40.48M 30.61M
Cost of revenue 50.47M 0.31M 0.30M 0.54M 0.47M
Total other income expense net 181.15M 5.70M 4.32M -0.07M 0.10M
Net income from continuing ops 265.34M 115.22M 82.79M 60.65M 44.44M
Net income applicable to common shares - - - 60.65M 44.44M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 609.28M 338.70M 257.43M 202.13M 157.05M
Intangible assets 22.05M 20.77M 20.07M 21.35M 22.29M
Other current assets 5.11M 6.58M 2.95M 0.78M 0.45M
Total liab 159.00M 81.74M 69.70M 63.36M 55.32M
Total stockholder equity 450.28M 256.96M 187.73M 138.78M 101.73M
Deferred long term liab - - - 2.36M 1.47M
Other current liab 27.71M 25.99M 29.86M 16.56M 14.48M
Common stock 49.53M 34.73M 23.65M 1.96M 1.96M
Capital stock 49.60M 34.73M 23.65M 1.96M 1.96M
Retained earnings 439.40M 239.46M 173.36M 127.12M 92.58M
Other liab - - - 31.31M 26.78M
Other assets - - 0.00M 14.81M 12.33M
Cash 146.28M 174.54M 60.06M 91.25M 63.66M
Total current liabilities 52.17M 43.14M 34.56M 30.85M 26.86M
Current deferred revenue 22.60M 19.11M 17.05M 12.60M 10.13M
Net debt -144.05M -172.28M -57.99M -89.40M -61.38M
Short term debt 0.77M 0.66M 0.55M 0.65M 0.60M
Short long term debt total 2.23M 2.25M 2.07M 1.85M 2.28M
Other stockholder equity - - -8.54M -129.07M -94.53M
Property plant equipment - - - 2.19M 2.60M
Total current assets 355.60M 280.09M 206.56M 163.79M 119.82M
Long term investments 189.36M 7.34M 7.34M - -
Net tangible assets - - - 117.43M 79.44M
Short term investments 104.00M 34.65M 95.36M 30.25M 26.90M
Net receivables 100.21M 64.23M 48.05M 39.88M 27.44M
Inventory - 0.10M 0.05M 0.06M 0.08M
Accounts payable 1.09M 1.41M 1.74M 1.03M 1.64M
Accumulated other comprehensive income -38.65M -17.23M -0.73M 9.70M 7.20M
Non currrent assets other 11.55M 3.94M 21.08M 2.60M 1.47M
Non current assets total 253.69M 58.61M 50.86M 38.34M 37.23M
Capital lease obligations 2.23M 2.25M 2.07M 1.85M 2.28M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments -9.99M -6.58M -73.28M -7.56M -8.53M
Change to liabilities - - - 7.14M 8.10M
Total cashflows from investing activities -21.25M -6.58M -73.28M -7.56M -16.91M
Net borrowings - - - -0.57M -0.51M
Total cash from financing activities -75.45M -57.62M -39.84M -27.53M -23.31M
Change to operating activities - - - 0.27M 0.35M
Net income 264.97M 75.76M 82.79M 60.65M 44.44M
Change in cash 44.25M 47.42M -31.19M 27.59M 21.62M
Begin period cash flow 102.03M 60.06M 91.25M 63.66M 42.04M
End period cash flow 146.28M 107.49M 60.06M 91.25M 63.66M
Total cash from operating activities 136.33M 111.33M 81.98M 62.53M 61.58M
Depreciation 8.05M 4.76M 5.67M 0.83M 0.81M
Other cashflows from investing activities - -2.59M -65.44M 2.24M 0.65M
Dividends paid 64.69M 49.11M 36.55M 26.11M 18.79M
Change to inventory - - 0.01M 0.02M -0.04M
Change to account receivables -33.51M - -9.99M -13.48M -3.59M
Sale purchase of stock -10.13M -7.85M -2.77M -0.84M -4.02M
Other cashflows from financing activities -0.63M -0.65M -0.52M -0.57M -0.51M
Change to netincome - - - -0.24M 0.40M
Capital expenditures 0.44M 7.38M 6.69M 6.45M 9.02M
Change in working capital 33.36M - -9.46M -13.46M -3.63M
Stock based compensation - - 1.93M 1.23M 0.03M
Other non cash items -170.05M 111.33M 6.72M 1.05M 16.32M
Free cash flow 135.89M 103.95M 75.29M 56.09M 52.55M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PMCUF
Pro Medicus Limited
-
-%
132.14 64.90 90.91 49.11 38.05 65.12 83.47
VEEV
Veeva Systems Inc Class A
7.42
2.45%
310.63 43.49 29.59 12.48 5.79 10.39 33.41
TEM
Tempus AI, Inc. Class A Common Stock
-2.19
2.81%
75.61 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc
-0.50
8.77%
5.20 31.84 26.25 0.05 4.60 0.04 0.12
BTSG
BrightSpring Health Services, Inc. Common Stock
-0.04
0.06%
69.80 100.22 40.65 0.69 4.92 0.92 25.80

Profile*

Pro Medicus Limited

Pro Medicus Limited, a healthcare informatics company, provides medical imaging software and services to hospitals, imaging centers, and health care groups in Australia, Europe, and North America. The company offers Visage RIS, an enterprise-class radiology information system for patient registration, billing, scheduling, typing, HL7 integration, financial reporting, picture archive and communication system (PACS) integration, digital dictation, and voice recognition integration; and Visage RIS/PACS, a solution for imaging needs of organizations. It also provides Visage 7 Enterprise Imaging Platform, a healthcare imaging software for radiologists, physicians, and clinicians for access and visualization capability comprising rapidly viewing 2-D, 3-D, and 4-D medical images, as well as PACS, digital imaging software, training, installation, and professional services and support products; and Visage Ease, a native mobile application for access to medical imaging results stored on a Visage 7 server from iOS devices, including iPad, iPhone, and iTouch. In addition, the company offers Visage Ease Pro for interpreting diagnostic imaging studies; and Promedicus.net, an e-health offering. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

450 Swan Street, Richmond, VIC, Australia, 3121

61 3 9429 8800

153

Name Title Year Born
Dr. Sam Aaron Hupert M.B.B.S., M.D. Co-Founder, CEO, MD & Exec. Director NA
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. Co-Founder, Technology Director & Exec. Director NA
Mr. Clayton James Hatch CPA, B.Comm, CPA CFO & Company Sec. NA
Dr. Malte Westerhoff GM of Europe & Global CTO NA
Mr. Brad Levin GM of North America & Global Head of Marketing NA
Mr. Sean Lambright Global Head of Sales - Visage Imaging Inc NA
Ms. Teresa Gschwind Global Head of Customer Service of Visage Imaging Inc. NA
Dr. Sam Aaron Hupert M.B.B.S., M.D. Co-Founder, CEO, MD & Executive Director NA
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. Co-Founder, Technology Director & Executive Director NA
Ms. Danny English C.A. Chief Financial Officer & Company Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…